Salituro G

Title : Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes - Biftu_2014_J.Med.Chem_57_3205

Author(s) : Biftu T , Sinha-Roy R , Chen P , Qian X , Feng D , Kuethe JT , Scapin G , Gao YD , Yan Y , Krueger D , Bak A , Eiermann G , He J , Cox J , Hicks J , Lyons K , He H , Salituro G , Tong S , Patel S , Doss G , Petrov A , Wu J , Xu SS , Sewall C , Zhang X , Zhang B , Thornberry NA , Weber AE

Ref : Journal of Medicinal Chemistry , 57 :3205 , 2014

Abstract :

PubMedSearch : Biftu_2014_J.Med.Chem_57_3205

PubMedID: 24660890

Gene_locus related to this paper: human-DPP4

Title : Hypothemycin inhibits the proliferative response and modulates the production of cytokines during T cell activation - Camacho_1999_Immunopharmacology_44_255

Author(s) : Camacho R , Staruch MJ , Dasilva C , Koprak S , Sewell T , Salituro G , Dumont FJ

Ref : Immunopharmacology , 44 :255 , 1999

Abstract :

PubMedSearch : Camacho_1999_Immunopharmacology_44_255

PubMedID: 10598882

Gene_locus related to this paper: hypsb-hpm3

Salituro G

References (2)

1. Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes - Biftu_2014_J.Med.Chem_57_3205

2. Hypothemycin inhibits the proliferative response and modulates the production of cytokines during T cell activation - Camacho_1999_Immunopharmacology_44_255